Chad Whited, MD
Otolaryngology · Austin, TXNPI 1255575817
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,821 of the $11,712 with a category attached, or 83.9%. It is spread thinly across 29 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $3,577 and has fallen 58.1% since, to $1,497 in 2025. Among otolaryngology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 235 payments — averaging $49.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$2K
- Sanofi$1K
- Aerin Medical Inc.$1K
- Olympus America Inc.$1K
- Stryker$1K
- Medtronic$596
- plus $4K from 23 others
What the payments were for
- Consulting fees$1,87516%
- Travel & lodging$160%
- Food & beverage$9,82184%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 6 | $1,951 |
| Sanofi | 45 | $1,404 |
| Aerin Medical Inc. | 20 | $1,166 |
| Olympus America Inc. | 20 | $1,160 |
| Stryker | 24 | $1,013 |
| Medtronic(2 entities) | 8 | $596 |
| Acclarent, Inc | 17 | $556 |
| Optinose US, Inc. | 20 | $539 |
| Inspire Medical Systems, Inc. | 6 | $524 |
| Regeneron Healthcare Solutions, Inc. | 15 | $445 |
| Integra Lifesciences Corporation | 7 | $412 |
| GSK | 7 | $311 |
| Intersect ENT, Inc. | 3 | $199 |
| Johnson & Johnson | 3 | $197 |
| Acera Surgical, Inc. | 2 | $192 |
| AbbVie(2 entities) | 5 | $119 |
| Kaleo, Inc. | 5 | $110 |
| Cvrx, Inc. | 1 | $100 |
| Tactile Systems Technology Inc | 1 | $96 |
| Cochlear Americas | 1 | $92 |
| Masimo Corporation | 2 | $89 |
| Axogen | 1 | $86 |
| Ambu Inc. | 1 | $75 |
| Alk-abello, Inc | 4 | $71 |
| Hikma Pharmaceuticals USA | 4 | $64 |
| Covidien LP | 3 | $60 |
| Itamar Medical Inc | 2 | $37 |
| Medrobotics Inc. | 1 | $25 |
| Merck | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Coblation$1,875
- VIVAER STYLUS$527
- RHINAER STYLUS$527
- Acclarent Aera$284
- Inspira Air$284
- RELIEVA SPINPLUS NAV$284
- TruDi Probe$284
- Inspire$258
- NUCALA$237
- ENTELLUS - XPRESS ENT DILATION SYSTEM$168
- Restrata Wound Matrix$162
- NIM Vital$159
- Inspire Upper Airway Stimulation System$159
- Olympus$155
- RHINO-LARYNGO FIBERSCOPE$155
- RHINO-LARYNGO VIDEOSCOPE$141
- PROPEL$140
- ENTELLUS - ENTELLUS MEDICAL REINFORCED ANESTHESIA NEEDLE$140
- Olympus Capital Accessories$138
- DUPIXENT$122
How this compares
$11,712 in reported general payments places this provider in the 90th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 212 | $5,392 |
| Epinephrine | 11 | $2,000 |
| Mometasone Furoate | 12 | $1,467 |
| Wixela InhubFluticasone Propion/Salmeterol | 11 | $1,366 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 39 | $681 |
| Amitriptyline Hcl | 56 | $675 |
| Gabapentin | 59 | $559 |
| Fluconazole | 28 | $345 |
| Ofloxacin | 15 | $282 |
| Glycopyrrolate | 11 | $251 |
| Azelastine Hcl | 13 | $239 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $225 |
| Tramadol Hcl | 50 | $154 |
| Omeprazole | 22 | $80 |
| Methylprednisolone | 11 | $80 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USAEpinephrine | $64 | $2,00011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 729 otolaryngology providers in Texas.
Other otolaryngology in Austin
- Daniel SlaughterAustin$18K
- Karen StiermanAustin$17K
- Marc DeanFort Worth$486K
- Amber LuongHouston$426K
- Arjuna KuperanHouston$348K
- Ronald KuppersmithCollege Station$325K
- Ron KarniHouston$317K
- Philip ChenSan Antonio$305K
- Jordan RihaniSouthlake$280K
- Keith MathenyFrisco$269K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.